Combined tests provide most data for Alzheimer's diagnosis

12/11/2012 |

Combining MRI, FDG-PET and cerebrospinal fluid analysis provided the most data for diagnosing Alzheimer's disease and allowed researchers to achieve the lowest misclassification rate of 28.4% when compared with neuropsychological testing, according to a study by Duke Medicine researchers. They also observed that of the three methods, FDG-PET provided the most data for use in diagnosing early Alzheimer's in people with mild cognitive impairment. More studies are needed to further understand the use of the tests in the clinical environment, researchers said.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD